COMPARATIVE STUDY OF BETA-LACTAM MONOTHERAPY VERSUS COMBINATION OF BETA-LACTAM ALONG WITH OTHER ANTIBIOTIC THERAPY FOR THE TREATMENT OF LRTI IN PEDIATRICS.

Registration ID: IJNRD_301876

Published ID: IJNRD2411103

: Click Here to Get

Bakshi Divya, Anaswara C, B.Saikiran, Bhuvana S, Dr. Lokesh S V

Beta lactam antibiotics, LRTI, monotherapy, combination therapy, PRESS score.

COMPARATIVE STUDY OF BETA-LACTAM MONOTHERAPY VERSUS COMBINATION OF BETA-LACTAM ALONG WITH OTHER ANTIBIOTIC THERAPY FOR THE TREATMENT OF LRTI IN PEDIATRICS Short title: Comparison of antibiotics used in LRTI in Pediatrics. Abstract: Background: This study was done to compare the effectiveness of Beta lactam monotherapy versus combination of Beta lactam along with other antibiotics therapy for treating the LRTI in Pediatrics. A total of 75 patients included in this study who are of age between 3 months to 18 years. The most frequent presenting complaints were cough, fever, and breathlessness, signifying the serious condition of the patient, requiring hospitalization. The common diagnosis are Pneumonia and Bronchiolitis. Objectives: The primary objective of this study is to compare the effectiveness and tolerability of β-Lactam monotherapy Vs combination of β-Lactam along with other antibiotics therapy for the treatment of LRTI in Pediatrics and to compare the duration of hospital, stay on β-Lactam monotherapy Vs combination of β-Lactam along with another antibiotics therapy. Materials and methods: The present study was conducted in Pediatric department of BGS Global Institute of Medical Sciences (BGS-GIMS), Kengeri, Bengaluru, Karnataka. This is a comparative study of monotherapy vs combination therapy of beta lactam antibiotics in LRTI and the study was conducted for the period of 6 months. All children within the age of 3 month to 18 years admitted with LRTI in a pediatric department were included in the study. Results: Our study compares the effectiveness of monotherapy vs. combination therapy with commonly prescribed antibiotics for LRTI in children, primarily Ceftriaxone, Amoxicillin + Clavulanic acid, and Azithromycin. Most children recover fully, with a small portion developing chronic symptoms due to factors like immunosuppression and environmental conditions. Hospital stays and recovery times were similar between groups, with no significant difference in duration. Monotherapy had a higher pneumonia classification rate (48.1% vs. 38.1%) and underweight status (77.8% vs. 81%) compared to combination therapy. The PRESS score showed significant differences only on the first day of follow-up. Interpretation & Conclusions: Over all in the comparison between the beta lactam monotherapy and combination of beta lactam along with other antibiotic therapy we concluded that there was no significant difference between the both of them. Both are effective in the patients for their respective situation and can chose based on the benefit over risk to the patient.

Published Paper   E-Certificate

Bakshi Divya, Anaswara C, B.Saikiran, Bhuvana S, & Dr. Lokesh S V (November-2024). COMPARATIVE STUDY OF BETA-LACTAM MONOTHERAPY VERSUS COMBINATION OF BETA-LACTAM ALONG WITH OTHER ANTIBIOTIC THERAPY FOR THE TREATMENT OF LRTI IN PEDIATRICS.. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(11), b34-b54. https://ijnrd.org/papers/IJNRD2411103.pdf

Volume 9 Issue 11, November-2024

Pages : b34-b54

Paper Reg. ID: IJNRD_301876

Published Paper Id: IJNRD2411103

Downloads: 000122003

Research Area: Pharmacy All

Author Type: Indian Author

Country: Sangareddy, Telagana, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2411103.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2411103

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.

You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.

Call For Paper - Volume 10 | Issue 11 | November 2025

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.

For more details, refer to the official notice: UGC Public Notice

Submit Paper Online

Important Dates for Current issue

Paper Submission Open For: November 2025

Current Issue: Volume 10 | Issue 11 | November 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 30-Nov-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details

Approval, Licenses and Indexing: More Details